The weaker correlation of sNFL levels with age in ALS patients compared to NHCs is probably due to the NFL-raising effect exerted by ongoing MN degeneration overwhelming the similar but milder effect exerted by aging through subclinical neuronal loss (Verde et al., 2019). The gene discussed is NEFL; the disease is amyotrophic lateral sclerosis.